Q2 2012

Source filing unavailable

Q2 2012 · —

Revenue—

Net Income

$551.00K

N/M vs Q2 2011

EPS Diluted

$0.01

N/M vs Q2 2011

Gross Profit$7,367,000+58.2%

Operating Income$839,000N/M

Operating Cash Flowderived$1,081,000+120.6%

Same quarter

Metric	Q2 2012	Q2 2011	Q2 2010
Net Income	$551.00K	-$293.00K	-$978.00K
EPS Diluted	$0.01	-$0.01	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR